COMPASS Pathways plc

Informe acción NasdaqGS:CMPS

Capitalización de mercado: US$301.7m

COMPASS Pathways Dirección

Dirección controles de criterios 3/4

El CEO de COMPASS Pathways es Kabir Nath , nombrado en Aug 2022, tiene una permanencia de 2.25 años. compensación anual total es $2.82M, compuesta por 21% salario y 79% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.037% de las acciones de la empresa, por valor de $110.83K. La antigüedad media del equipo directivo y de la junta directiva es de 2.3 años y 4.2 años, respectivamente.

Información clave

Kabir Nath

Chief Executive Officer (CEO)

US$2.8m

Compensación total

Porcentaje del salario del CEO21.0%
Permanencia del CEO2.3yrs
Participación del CEO0.04%
Permanencia media de la dirección2.3yrs
Promedio de permanencia en la Junta Directiva4.2yrs

Actualizaciones recientes de la dirección

Recent updates

Compass Pathways: Minor Delay Of COMP360 Data Brings About Buy Opportunity

Nov 01

Compass Pathways: Sector-Wide Reality Check Needed Post FDA Lykos MDMA Decision

Aug 19

Compass Pathways: Buy It For Its Promising Psychedelic Mental Health Therapies

Jul 08

Psychedelics Closer To Commercialization; Compass Far And Away The Leader

May 23

COMPASS Pathways: Will MDMA-Assisted Therapy Pave The Way Or Slam The Door Shut?

Apr 25

Compass Pathways: Psilocybin Developer A Potentially Intriguing, Contrarian Play

Feb 08

Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth

Dec 06
Companies Like COMPASS Pathways (NASDAQ:CMPS) Are In A Position To Invest In Growth

Booker again pushes for easier access to psychedelics for terminally ill patients

Oct 19

Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation

Aug 13
Here's Why We're Not Too Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Situation

COMPASS Pathways And The Trillion Dollar Opportunity

Aug 11

COMPASS Pathways ADS Q2 2022 Earnings Preview

Aug 03

COMPASS Pathways names new CEO

Jul 19

Compass Pathways: Shares Look Cheap But Proving Psilocybin Case Won't Be Easy

Jun 30

We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely

Apr 28
We're Hopeful That COMPASS Pathways (NASDAQ:CMPS) Will Use Its Cash Wisely

Checking In On Compass Pathways

Mar 02

We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth

Dec 29
We Think COMPASS Pathways (NASDAQ:CMPS) Can Afford To Drive Business Growth

Compass Pathways: Psychedelics For Mental Health

Nov 23

Compass Faces Tricky Road To Approval For Its Psychedelic Depressive Therapy

Sep 17

COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

Sep 15
COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

Compass Pathways: Huge Growth Potential, But I'm Cautious

Jun 04

COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

May 25
COMPASS Pathways (NASDAQ:CMPS) Is In A Good Position To Deliver On Growth Plans

COMPASS Pathways raises $144M capital via equity offering

Apr 30

COMPASS Pathways launches public offering

Apr 27

We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate

Feb 08
We're Not Very Worried About COMPASS Pathways' (NASDAQ:CMPS) Cash Burn Rate

Psilocybin Will Change Mental Health, Compass Pathways Could Be At The Forefront

Jan 01

Compass Pathways: Risky And Overvalued

Dec 18

What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?

Dec 18
What Type Of Shareholders Make Up COMPASS Pathways plc's (NASDAQ:CMPS) Share Registry?

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Kabir Nath en comparación con los beneficios de COMPASS Pathways?
FechaCompensación totalSalarioIngresos de la empresa
Sep 30 2024n/an/a

-US$144m

Jun 30 2024n/an/a

-US$139m

Mar 31 2024n/an/a

-US$129m

Dec 31 2023US$3mUS$595k

-US$118m

Sep 30 2023n/an/a

-US$117m

Jun 30 2023n/an/a

-US$102m

Mar 31 2023n/an/a

-US$95m

Dec 31 2022US$8mUS$243k

-US$92m

Compensación vs. Mercado: La compensación total de Kabir($USD2.82M) está por encima de la media de empresas de tamaño similar en el mercado US ($USD2.16M).

Compensación vs. Ingresos: La compensación de Kabir ha sido consistente con los resultados de la empresa en el último año.


CEO

Kabir Nath (60 yo)

2.3yrs

Permanencia

US$2,824,758

Compensación

Mr. Kabir Kumar Nath M. A., M. B.A., is Chief Executive Officer and Director of COMPASS Pathways plc from August 1, 2022. He serves as President & CEO at Otsuka America Pharmaceutical, Inc. He served as Pr...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Kabir Nath
CEO & Director2.3yrsUS$2.82m0.037%
$ 110.8k
Matthew Owens
General Counsel & Chief Legal Officer2.8yrsUS$1.32m0.0059%
$ 17.8k
Guy Goodwin
Chief Medical Officer3.3yrsUS$1.20m0.0029%
$ 8.8k
Teri Loxam
CFO, Principal Financial Officer & Principal Accounting Officerless than a yearsin datossin datos
Greg Ryslik
Chief Technology Officer2.8yrssin datossin datos
Stephen Schultz
Senior Vice President of Investor Relationsno datasin datossin datos
Christopher Williams
Chief Communications Officer2.1yrssin datossin datos
Anne Benedict
Chief People Officerno datasin datossin datos
Lars Wilde
Senior Advisor2.8yrssin datossin datos
Susan Stansfield
Advisorno datasin datossin datos
Michael Gold
Chief Research & Development Officerless than a yearsin datossin datos
Lori Englebert
Chief Commercial Officerless than a yearsin datossin datos

2.3yrs

Permanencia media

51yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de CMPS se considera experimentado (2.3 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Kabir Nath
CEO & Director2.3yrsUS$2.82m0.037%
$ 110.8k
Alan Schatzberg
Member of Scientific Advisory Networkno datasin datossin datos
Linda McGoldrick
Independent Non Executive Director4.2yrsUS$209.48k0%
$ 0
Gino Santini
Chairmanless than a yearsin datossin datos
David Norton
Independent Director6.5yrsUS$215.57k0.025%
$ 76.7k
Daphne Karydas
Independent Director1.2yrsUS$363.71k0%
$ 0
Robert McQuade
Independent Non Executive Director4.6yrsUS$210.84k0%
$ 0
Wayne Riley
Independent Non-Executive Director3.7yrsUS$200.86k0%
$ 0
Thomas Lonngren
Independent Non-Executive Director6.5yrsUS$199.82k0.13%
$ 392.7k
Annalisa Lisa Jenkins
Independent Non-Executive Director6.5yrsUS$214.78k0.051%
$ 153.8k
Diego Pizzagalli
Member of Scientific Advisory Networkno datasin datossin datos
Gul Dolen
Member of Scientific Advisory Networkno datasin datossin datos

4.2yrs

Permanencia media

67yo

Promedio de edad

Junta con experiencia: La junta directiva de CMPS se considera experimentada (4.2 años de antigüedad promedio).